Martine Rothblatt

Bio:

Dr. Martine Rothblatt founded United Therapeutics in 1996 to discover a 
cure for her daughter's life-threatening rare disease, pulmonary arterial 
hypertension, and has served as Chairperson and Chief Executive Officer 
since its inception. Today, United Therapeutics focuses on transforming the 
treatment of rare diseases and pioneering alternatives to expand the supply 
of transplantable organs.
In 2026, Dr. Rothblatt was number eight on Forbes’ inaugural Innovator 250 list, which recognizes the 
250 living Americans who “best embody the nation’s creative spirit.” She was also elected to 
the National Academy of Engineering's class of 2026, which is among the highest professional 
distinctions that can be accorded to an engineer. Dr. Rothblatt received these honors for her 
leadership in the fields of spectrum and satellite engineering, biotechnology, organ transplantation, 
and electric aviation.
In 1990, she created the satellite radio company SiriusXM. She is an inventor or co-inventor on nine 
U.S. patents, with additional applications pending. Her pioneering book, Your Life or Mine: How 
Geoethics Can Resolve the Conflict Between Private and Public Interests in Xenotransplantation, 
anticipated the need both for global virus bio-surveillance and a greatly expanded supply of 
transplantable organs. Dr. Rothblatt also analyzed the socio-ethical issues of human-like cyber 
competencies in her 2014 book Virtually Human.
Dr. Rothblatt graduated summa cum laude with a degree in communications studies from the 
University of California, Los Angeles, in 1977. She also received dual J.D. and M.B.A. degrees 
from UCLA in 1981. She earned her Ph.D. in medical ethics from the Barts and The London School of 
Medicine and Dentistry, Queen Mary University of London, in 2001.